THE PRESENT DAY PERCEPTION OF THE PROBLEM OF IMMUNE RESTORATION OF UPON ART

Antiretroviral therapy (ART), which is intended to inhibit HIV replication, promotes partial restoration or activation of immunity. In many patients who have severe immunosuppression, ART may increase the risk of development of immune restoration syndrome (IRS), which is associated with the manifestations of opportunistic and secondary diseases that lead to worsening of the general health of patients and to their death. The present paper addresses IRS-related terminology, the risk factors of IRS development, and IRS pathogenesis, epidemiology, and clinical and laboratory manifestations. Special attention is paid to secondary and opportunistic infections associated with IRS and to the possibilities of pharmacotherapy for IRS and its complications. Characteristic radiological manifestations of brain lesions upon IRS are described as they as associated with different pathogenic factors upon initially poor immunity. It is hard to assess IRS incidence inRussia: IRS is diagnosed seldom becauseВИЧинфекция и иммуносупрессии,2018 г., Том 10, № 2 15 of the ambiguity of its clinical picture. A combination of the main clinical and laboratory manifestations of the syndrome is suggested to help in IRS diagnosis. IRS prevention is based on reasonable regiments of ART following preventing therapy for possible manifested infections and also on early ART onset upon steady CD4 cell counts and low HIV RNA blood levels.

1. Markelov Yu.M., Pahomova E.V., Rozhkova I.I. Distribution and mortality patterns in patients co-infected with HIV and TB in Karelia. HIV Infection and Immusupressive Disorders, 2016, Vol. 8, No. 3, pp. 65–73 (In Russ.).

2. Sharma S.K., Dhooria S., Barwad P., Kadhiravan T., Ranjan S., Miglani S. et al. A study of TB-associated immune reconstitution inflammatory syndrome using the consensus case-definition. Indian J. Med. Res., 2010, No. 131, pp. 804–808.

3. Sharma S.K., Soneja M. HIV & immune reconstitution inflammatory syndrome (IRIS). Indian J. Med. Res., 2011, Vol. 134 (6), pp. 866–877.

4. 26Pokrovskiy V.V. HIV infection and AIDS: national leadership. Moscow: GEOTAR-Media, 2013, 608 p. (In Russ.).

5. Walker N.F., Scriven J., Meintjes G., Wilkinson R.J. Immune reconstitution inflammatory syndrome in HIV-infected patients. HIV AIDS (Auckl), 2015, No. 7, pp. 49–64.

6. Dominique J., Pepper D.J., Marais S., Maartens G., Rebe K., Morroni C., Rangaka M.X., Oni T., Wilkinson R.J., Meintjes G. Neurologic Manifestations of Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome: A Case Series. Clin. Infect. Dis., 2009, No. 48, pp. 96–107.

7. Vendrely A., Bienvenu B., Gasnault J., Thiebault J.B., Salmon D., Gray F. Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy. Acta Neuropathol., 2005, No. 109, pp. 449–455.

8. Bitneva A.M., Kozlova T.P., Savintseva E.V. Features of the onset and course of theHIV Infection and Immunosuppressive immune reconstitution inflammatory syndrome in patients with pulmonary tuberculosis. Problems Sciences, 2017, No. 6 (19), pp. 104–105 (In Russ.).

9. Zimina V.N., Vasil’eva I.A., Batyrov F.A. Acute development of tuberculosis of intrathoracic lymph nodes as manifestations of immune reconstitution inflammatory syndrome in patients with HIV infection. Tuberculosis and Lung Diseases, 2010, Vol. 87, No. 4, pp. 58–60 (In Russ.).

10. HIV 2014/2015. Eds. C.Hoffman, Yu.K.Rockstroh. 2015, 755 p. URL: https://arvt.ru/sites/default/files/hivbook_2015_rus_opt.pdf (In Russ.).

11. Zimina V.N., Kravchenko A.V., Zyuzya Yu.P., Vasil’eva I.A. Diagnosis and treatment of tuberculosis in combination with HIV infection. Moscow: GEOTAR-Media, 2015, 240 p. (In Russ.).

12. Zakharova N.G., Dvorak S.I., Plavinskiy S.L. The causes of unfavorable outcomes amoung patients taking HAART. Part 1. HIV Infection and Immusupressive Disorders, 2015, Vol. 7, No. 3, pp. 48–54 (In Russ.).

13. Zagdyn Z.M. Preventive TB treatment in HIV patients. HIV Infection and Immusupressive Disorders, 2014, Vol. 6, No. 4, pp. 17–23 (In Russ.).

14. Tishchenko G.V., Tsyrkunov V.M. Immune reconstitution inflammatory syndrome in HIV-infected patients: clinical and morphological aspects. Health Care (Minsk), 2017, No. 10, pp. 5–11 (In Russ.).

15. Korzh E.V. Modern views on antiretroviral therapy in patients with co-infection with tuberculosis/HIV. Tuberculosis, Lung diseases, HIV infection, 2012, No. 1 (8), pp. 115–121 (In Russ.).

16. Shelburne S.A., Montes M., Hamill R.J. Immune reconstitution inflammatory syndrome: more answers, more questions. J. Antimicrob. Chemother., 2006, Vol. 57 (2), pp. 167–170.

17. Phillips P., Bonner S., Gataric N., Bai T., Wilcox P., Hogg R. et al. Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up. Clin. Infect. Dis., 2005, No. 41, pp. 1483–1497.

18. Kaplan J.E., Benson C., Holmes K.H., Brooks J.T., Pau A., Masur H. Centers for Disease Control and Prevention (CDC); National Institutes of Health; HIV Medicine Association of the Infectious Diseases Society of America. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm. Rep., 2009, No. 58, pp. 1–207.ВИЧинфекция и иммуносупрессии, 2018 г., Том 10, № 2 25

19. Bicanic T., Harrison T.S. Cryptococcal meningitis. Br. Med. Bull., 2004, Vol. 72, No. 1, pp. 99–118.

20. Murdoch D.M., Venter W.D., Van R.A., Feldman C. Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options. AIDS Res. Ther., 2007, No. 4, pp. 9–10.

21. Bicanic T., Meintjes G., Rebe K., Williams A., Loyse A., Wood R. et al. Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis: a prospective study. J. Acquir. Immune Defic. Syndr., 2009, Vol. 51 (2), pp. 130–134.

22. Matiyevskaya N.V. Immune reconstitution inflammatory syndrome (IRIS) in HIV-infected patients: risk factors, clinical features, outcomes, prevention. Bulletin of the Baltic Federal University I.Kant. Series: Natural and medical sciences, 2012, No. 7, pp. 44–51.

23. McCombe J.A., Auer R.N., Maingat F.G., Houston S., Gill M.J., Power C. Neurologic immune reconstitution inflammatory syndrome in HIV/AIDS: outcome and epidemiology. Neurology, 2009, No. 72, pp. 835–841.

24. French M.A. HIV/AIDS: immune reconstitution inflammatory syndrome: a reappraisal. Clin. Infect. Dis., 2009, No. 48, pp. 101–107.

25. Muller M., Wandel S., Colebunders R., Attia S., Furrer H., Egger M. Immune reconstitution inflammatory. Lancet Infect. Dis., 2010, No. 10, pp. 449–455.

26. Jevtović D.J., Salemović D., Ranin J., Pesić I., Zerjav S., Djurković-Djaković O. The prevalence and risk of immune restoration disease in HIVinfected patients treated with highly active antiretroviral therapy. HIV Med., 2005, Vol. 6 (2), pp. 140–143.

27. Gopal R., Rapaka R.R., Kolls J.K. Immune reconstitution inflammatory syndrome associated with pulmonary pathogens. Eur. Respir. Rev., 2017, Vol. 26 (143), pp. e160042.

28. French M.A., Price P., Stone S.F. Immune restoration disease after antiretroviral therapy. AIDS, 2004, Vol. 18, No. 12, pp. 1615–1627.

29. George V., Harrison L., Roach M. Associations of Plasma Cytokine and Microbial Translocation Biomarkers With Immune ReconstitutionInflammatory Syndrome. J. Infect. Dis., 2017, Vol. 216 (9), pp. 1159–1163.

30. Jagannathan P., Davis E., Jacobson M., Huang L. Life-threatening immune reconstitution inflammatory syndrome after Pneumocystis pneumonia: a cautionary case series. AIDS, 2009, No. 23, pp. 1794–1796.

31. Wiesner D.L., Boulware D.R. Cryptococcus-Related Immune Reconstitution Inflammatory Syndrome (IRIS): Pathogenesis and Its Clinical Implications. Curr. Fungal Infect. Rep., 2011, Vol. 5 (4), pp. 252–261.

32. Stepanova E.V. Herpesvirus and HIV infection. Saint-Petersburg: Baltic medical education center, 2009, 60 p. (In Russ.).

33. Simbirtsev A.S. Immunopathogenesis of and prospects for immunomodulatory therapy for HIV infection. Part 1. The general aspects of immunology and HIV. HIV Infection and Immusupressive Disorders, 2017, Vol. 9, No. 1, pp. 22–35 (In Russ.).

34. Dunić I., Djurković-Djaković O., Vesić S., Zerjav S., Jevtović D. Herpes zoster as an immune restoration disease in AIDS patients during therapy including protease inhibitors. Int. J. STD AIDS, 2005, No. 16, pp. 475–478.

35. Haddow L.J., Moosa M.Y., Easterbrook P.J. Validation of a published case definition for tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS, 2010, Vol. 24 (1), pp. 103–108.

36. Anderson A.M., Mosunjac M.B., Fountain J.A., Corey A.S., Oshinski J.N. Simultaneous typical and extraordinary imaging findings of AIDS-associated cytomegalovirus encephalitis. J. Neurol. Sci., 2011, Vol. 307 (1–2), pp. 174–177.

37. Boulware D.R., Meya D.B., Bergemann T.L., Wiesner D.L., Rhein J., Musubire A. et al. Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome. PLoS Med., 2010, No. 7, pp. e1000384.

38. Shmidt T.E. Progressive multifocal leukoencephalopathy and other neurological symptoms of JC virus reactivation. Neurological Journal, 2014, Vol. 19, No. 4, pp. 4–10 (In Russ.).

39. Azovtseva O.V., Arkhipov G.S., Arkhipova E.I. A comparative analysis of causes of death in HIV infected patients. HIV Infection and Immusupressive Disorders, 2015, Vol. 7, No. 4, pp. 86–91 (In Russ.).

40. Katz-Brull R., Lenkinski R.E., Du Pasquier R.A., Koralnik I.J. Elevation of myoinositol is associated with disease containment in progressive multifocal leukoencephalopathy. Neurology, 2004, Vol. 63, No. 5, pp. 897–900.

41. Leonova O.N., Stepanova E.V., Belyakov N.A. Severe and comorbid conditions in HIV patients: an analysis of adverse outcomes. HIV Infection and Immusupressive Disorders, 2017, Vol. 9, No. 1, pp. 55–62 (In Russ.).

42. Post M.J.D., Thurnher M.M., Clifford D.B., Nath A., Gonzalez R.G., Gupta R.K., Post K.K. CNS-immune reconstitution inflammatory syndrome in the setting of HIV infection, part 1: overview and discussion of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome and cryptococcal-immune reconstitution inflammatory syndrome. Am. J. Neuroradiol., 2013, No. 34, pp. 1297–1307.

43. Musatov V.B., Yakovlev A.A., Savchenko M.A., Sokolova O.I. Lethal outcomes in HIV positive patients with undetectable viral load on antiretroviral therapy. Infectious Diseases: News, Opinions, Training, 2017, No. 4 (21), pp. 67–71 (In Russ.).

44. Jaffe H.W., De Stavola B.L., Carpenter L.M., Porter K., Cox D.R. CASCADE Collaboration. Immune reconstitution and risk of Kaposi sarcoma and non-Hodgkin lymphoma in HIV-infected adults. AIDS, 2011, Vol. 25 (11), pp. 1395–1403.

45. Rakhmanova A.G., Yakovlev A.A., Dmitrieva M.I., Vinogradova T.N., Kozlov A.A. Analysis of the causes of death in HIV-infected individuals in 2008–2010 according to the data of the Clinical Infectious Disease Hospital named after S.P.Botkin, SaintPetersburg. Kazan Medical Journal, 2012, Vol. 93, No. 3, pp. 522–526 (In Russ.).

46. Letang E., Almeida J.M., Miro J.M., Ayala E., White I.E., Carrilho C. et al. Predictors of immune reconstitution inflammatory syndrome-associated with Kaposi sarcoma in Mozambique: a prospective study. J. Acquir. Immune Defic. Syndr., 2010, No. 53, pp. 589–597.

47. Stepanova E.V., Leonova O.N., Panteleeva O.V. Causes of severe course and death in patients with HIV and co-infection. HIV Infection and Immusupressive Disorders, 2014, Vol. 6, No. 4, pp. 115 –117 (In Russ.).

48. Belov B.S., Belova O.L. HIV infection: rheumatological aspects. Russian Medicine Journal, 2008, Vol. 16, No. 24, pp. 1615–1618 (In Russ.).

49. Markelov Yu.M., Pahomova E.V., Rozhkova I.I. Distribution and mortality patterns in patients co-infected with HIV and TB in Karelia. HIV Infection and Immusupressive Disorders, 2016, Vol. 8, No. 3, pp. 65–73 (In Russ.).

50. Cherenko S.A., Matveeva S.L. Causes of thyroid dysfunction of homeostasis in co-infection with tuberculosis/HIV. Tuberculosis, Lung Diseases, HIV Infection, 2014, No. 1 (16), pp. 8–12 (In Russ.).

51. 26Pokrovskiy V.V. HIV infection and AIDS: national leadership. Moscow: GEOTAR-Media, 2013, 608 p. (In Russ.).

52. Crum N.F., Ganesan A., Johns S.T., Wallace M.R. Graves disease: an increasingly recognized immune reconstitution syndrome. AIDS, 2006, No. 20, pp. 466–469.

53. Dominique J., Pepper D.J., Marais S., Maartens G., Rebe K., Morroni C., Rangaka M.X., Oni T., Wilkinson R.J., Meintjes G. Neurologic Manifestations of Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome: A Case Series. Clin. Infect. Dis., 2009, No. 48, pp. 96–107.

54. Oelschlaeger C., Dziewas R., Minnerup J., Niederstadt T., Ringelstein E.B., Husstedt I.W. Severe leukoencephalopathy with fulminant cerebral edema reflecting immune reconstitution inflammatory syndrome during HIV infection: a case report. J. Med. Case Reports, 2010, No. 4, pp. 214.

55. Bitneva A.M., Kozlova T.P., Savintseva E.V. Features of the onset and course of theHIV Infection and Immunosuppressive immune reconstitution inflammatory syndrome in patients with pulmonary tuberculosis. Problems Sciences, 2017, No. 6 (19), pp. 104–105 (In Russ.).

56. Bojko A.V. Immune reconstitution inflammatory syndrome in patients with co-infection tuberculosis/ HIV/AIDS. Bulletin of Council of Young Scientists and Specialists of Chelyabinsk Region, 2014, No. 5 (7), pp. 5–7 (In Russ.).

57. Zimina V.N., Vasil’eva I.A., Batyrov F.A. Acute development of tuberculosis of intrathoracic lymph nodes as manifestations of immune reconstitution inflammatory syndrome in patients with HIV infection. Tuberculosis and Lung Diseases, 2010, Vol. 87, No. 4, pp. 58–60 (In Russ.).

58. Yakovlev A.A., Musatov V.B., Savchenko M.A. Causes of death amoung HIV infected patients receiving antiretroviral therapy. HIV Infection and Immusupressive Disorders, 2015, Vol. 7, No. 1, pp. 84–88 (In Russ.).

59. Zimina V.N., Kravchenko A.V., Zyuzya Yu.P., Vasil’eva I.A. Diagnosis and treatment of tuberculosis in combination with HIV infection. Moscow: GEOTAR-Media, 2015, 240 p. (In Russ.).

60. Shelomov A.S., Stepanova E.V., Leonova O.N., Smirnova N.L. Opportunistic diseases as the cause of damage to the central nervous system in patientswith HIV infection. Journal of Infectology, 2016, Vol. 8, No. 3, pp. 107–115 (In Russ.).

61. Zagdyn Z.M. Preventive TB treatment in HIV patients. HIV Infection and Immusupressive Disorders, 2014, Vol. 6, No. 4, pp. 17–23 (In Russ.).

62. Korzh E.V. Modern views on antiretroviral therapy in patients with co-infection with tuberculosis/HIV. Tuberculosis, Lung diseases, HIV infection, 2012, No. 1 (8), pp. 115–121 (In Russ.).

63. Phillips P., Bonner S., Gataric N., Bai T., Wilcox P., Hogg R. et al. Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up. Clin. Infect. Dis., 2005, No. 41, pp. 1483–1497.

64. Bicanic T., Harrison T.S. Cryptococcal meningitis. Br. Med. Bull., 2004, Vol. 72, No. 1, pp. 99–118.

65. Bicanic T., Meintjes G., Rebe K., Williams A., Loyse A., Wood R. et al. Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis: a prospective study. J. Acquir. Immune Defic. Syndr., 2009, Vol. 51 (2), pp. 130–134.

66. McCombe J.A., Auer R.N., Maingat F.G., Houston S., Gill M.J., Power C. Neurologic immune reconstitution inflammatory syndrome in HIV/AIDS: outcome and epidemiology. Neurology, 2009, No. 72, pp. 835–841.

67. Muller M., Wandel S., Colebunders R., Attia S., Furrer H., Egger M. Immune reconstitution inflammatory. Lancet Infect. Dis., 2010, No. 10, pp. 449–455.

68. Gopal R., Rapaka R.R., Kolls J.K. Immune reconstitution inflammatory syndrome associated with pulmonary pathogens. Eur. Respir. Rev., 2017, Vol. 26 (143), pp. e160042.

69. Jagannathan P., Davis E., Jacobson M., Huang L. Life-threatening immune reconstitution inflammatory syndrome after Pneumocystis pneumonia: a cautionary case series. AIDS, 2009, No. 23, pp. 1794–1796.

70. Stepanova E.V. Herpesvirus and HIV infection. Saint-Petersburg: Baltic medical education center, 2009, 60 p. (In Russ.).

71. Dunić I., Djurković-Djaković O., Vesić S., Zerjav S., Jevtović D. Herpes zoster as an immune restoration disease in AIDS patients during therapy including protease inhibitors. Int. J. STD AIDS, 2005, No. 16, pp. 475–478.

72. Anderson A.M., Mosunjac M.B., Fountain J.A., Corey A.S., Oshinski J.N. Simultaneous typical and extraordinary imaging findings of AIDS-associated cytomegalovirus encephalitis. J. Neurol. Sci., 2011, Vol. 307 (1–2), pp. 174–177.

73. Shmidt T.E. Progressive multifocal leukoencephalopathy and other neurological symptoms of JC virus reactivation. Neurological Journal, 2014, Vol. 19, No. 4, pp. 4–10 (In Russ.).

74. Katz-Brull R., Lenkinski R.E., Du Pasquier R.A., Koralnik I.J. Elevation of myoinositol is associated with disease containment in progressive multifocal leukoencephalopathy. Neurology, 2004, Vol. 63, No. 5, pp. 897–900.

75. Post M.J.D., Thurnher M.M., Clifford D.B., Nath A., Gonzalez R.G., Gupta R.K., Post K.K. CNS-immune reconstitution inflammatory syndrome in the setting of HIV infection, part 1: overview and discussion of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome and cryptococcal-immune reconstitution inflammatory syndrome. Am. J. Neuroradiol., 2013, No. 34, pp. 1297–1307.

76. Jaffe H.W., De Stavola B.L., Carpenter L.M., Porter K., Cox D.R. CASCADE Collaboration. Immune reconstitution and risk of Kaposi sarcoma and non-Hodgkin lymphoma in HIV-infected adults. AIDS, 2011, Vol. 25 (11), pp. 1395–1403.

77. Letang E., Almeida J.M., Miro J.M., Ayala E., White I.E., Carrilho C. et al. Predictors of immune reconstitution inflammatory syndrome-associated with Kaposi sarcoma in Mozambique: a prospective study. J. Acquir. Immune Defic. Syndr., 2010, No. 53, pp. 589–597.

78. Belov B.S., Belova O.L. HIV infection: rheumatological aspects. Russian Medicine Journal, 2008, Vol. 16, No. 24, pp. 1615–1618 (In Russ.).

79. Cherenko S.A., Matveeva S.L. Causes of thyroid dysfunction of homeostasis in co-infection with tuberculosis/HIV. Tuberculosis, Lung Diseases, HIV Infection, 2014, No. 1 (16), pp. 8–12 (In Russ.).

80. Crum N.F., Ganesan A., Johns S.T., Wallace M.R. Graves disease: an increasingly recognized immune reconstitution syndrome. AIDS, 2006, No. 20, pp. 466–469.

81. Oelschlaeger C., Dziewas R., Minnerup J., Niederstadt T., Ringelstein E.B., Husstedt I.W. Severe leukoencephalopathy with fulminant cerebral edema reflecting immune reconstitution inflammatory syndrome during HIV infection: a case report. J. Med. Case Reports, 2010, No. 4, pp. 214.

82. Bojko A.V. Immune reconstitution inflammatory syndrome in patients with co-infection tuberculosis/ HIV/AIDS. Bulletin of Council of Young Scientists and Specialists of Chelyabinsk Region, 2014, No. 5 (7), pp. 5–7 (In Russ.).

83. Yakovlev A.A., Musatov V.B., Savchenko M.A. Causes of death amoung HIV infected patients receiving antiretroviral therapy. HIV Infection and Immusupressive Disorders, 2015, Vol. 7, No. 1, pp. 84–88 (In Russ.).

84. Shelomov A.S., Stepanova E.V., Leonova O.N., Smirnova N.L. Opportunistic diseases as the cause of damage to the central nervous system in patientswith HIV infection. Journal of Infectology, 2016, Vol. 8, No. 3, pp. 107–115 (In Russ.).